MM patients who relapsed post-CAR T had significant subsets of PD1+ T cells, with some expressing other co-inhibitory molecules such as TIGIT, KLGR1, and BAFF [30,31]. This evidence concerns the gene TNFSF13B and Miyoshi myopathy.